Lentiviral Gene Therapy for Epilepsy
Condition(s):Drug Resistant EpilepsyLast Updated:May 24, 2022Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Drug Resistant EpilepsyLast Updated:May 24, 2022Not yet recruiting
Condition(s):Non-small Cell Lung CancerLast Updated:March 11, 2022Recruiting
Condition(s):Gene TherapyLast Updated:March 27, 2020Recruiting
Condition(s):Severe Combined Immunodeficiency Due to RAG1 DeficiencyLast Updated:December 17, 2021Recruiting
Condition(s):Glioblastoma Multiforme; Astrocytoma, Grade IIILast Updated:September 7, 2020Recruiting
Condition(s):Glioblastoma; Anaplastic AstrocytomaLast Updated:September 7, 2020Recruiting
Condition(s):Hemophilia ALast Updated:May 23, 2022Not yet recruiting
Condition(s):HemophiliaLast Updated:May 12, 2021Not yet recruiting
Condition(s):Hemophilia ALast Updated:January 28, 2022Active, not recruiting
Condition(s):Gene Therapy; Hemophilia BLast Updated:May 26, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.